Drugs / Videx EC
Regulatory milestones approvals, filings & regulatory actions · 4 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (3) | US (FDA) | VIDEX EC | — | 2002-01-29 – 2008-09-29 | fda.gov ↗ |
| Approved | US (FDA) | VIDEX EC | — | 2000-10-31 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00135382 Background | Jun 2002 → Oct 2005 | HIV infectious disease | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Videx EC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00135382 ↗ |